Research ArticleHuman Studies
Clinical Significance of Striatal DOPA Decarboxylase Activity in Parkinson's Disease
Tatsuya Ishikawa, Vijay Dhawan, Thomas Chaly, Claude Margouleff, William Robeson, J. Robert Dahl, Francince Mandel, Phoebe Spetsieris and David Eidelberg
Journal of Nuclear Medicine February 1996, 37 (2) 216-222;
Tatsuya Ishikawa
Vijay Dhawan
Thomas Chaly
Claude Margouleff
William Robeson
J. Robert Dahl
Francince Mandel
Phoebe Spetsieris


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Clinical Significance of Striatal DOPA Decarboxylase Activity in Parkinson's Disease
Tatsuya Ishikawa, Vijay Dhawan, Thomas Chaly, Claude Margouleff, William Robeson, J. Robert Dahl, Francince Mandel, Phoebe Spetsieris, David Eidelberg
Journal of Nuclear Medicine Feb 1996, 37 (2) 216-222;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls
- Relationship of Striatal Dopamine Synthesis Capacity to Age and Cognition
- Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease
- Pathophysiology of parkinsonism due to hydrocephalus
- Comparative Analysis of Striatal FDOPA Uptake in Parkinson's Disease: Ratio Method Versus Graphical Approach